Featured Research

from universities, journals, and other organizations

Experts discover a new neurotransmitter with potential applications in the treatment of neurological diseases

Date:
May 5, 2011
Source:
Universidad de Barcelona
Summary:
A team of scientists has discovered that D-aspartic acid (D-Asp) is a novel neurotransmitter that could potentially be used in the fight against neurological diseases such as Parkinson’s and schizophrenia.

A team of scientists has discovered that D-aspartic acid (D-Asp) is a novel neurotransmitter that could potentially be used in the fight against neurological diseases such as Parkinson's and schizophrenia.

The research paper, published in the Journal of Federation of American Societies for Experimental Biology (The FASEB Journal), is authored by Jordi García-Fernàndez, Salvatore D'Aniello and Ildiko Somorjai, from the UB's Department of Genetics and the Institute of Biomedicina of the University of Barcelona (IBUB), and by Enza Topo and Antimo D'Aniello, from the Department of Neurobiology of the Anton Dohrn Zoological Research Station in Naples.

D-Asp is an amino acid that was discovered in 1977 in the brains of squid and octopus by a research group coordinated by Antimo D'Aniello (Zoological Research Station, Naples). Since its discovery, this molecule has been the subject of several studies carried out in Italy and around the world. The article published in the FASEB Journal provides the first description of the activity of D-aspartic acid as a neurotransmitter in two evolutionary distinct animal species: the brown rat (Rattus norvergicus) and the European squid (Loligo vulgaris).

Salvatore D'Aniello, first author of the article, explains that, "The first chemical neurotransmitters were discovered some 40 years ago, but until now no study had made such a simple but novel discovery. D-Asp is no different to other classic amino acid neurotransmitters such as serine or glutamate, which have already been extensively researched." Neurotransmitters are molecules that transmit chemical signals in the nervous system. Synaptic transmission, which can be either electrical or chemical, is facilitated by 20 chemical neurotransmitters, including amino acids (L-glutamine, GABA) peptides (copamine, noradrenaline, vasopressin, insulin), amines (adrenaline, serotonin) or gases (nitric oxide, sulphuric acid).

"In our study," explains Salvatore D'Aniello, "we found that D-Asp meets all of the criteria that characterize biological molecules that exhibit neurotransmitter activity: they are present in high concentrations in the synaptic vesicles of axon terminals; synthesis for this amino acid occurs in neurons by conversion of L-Asp to D-Asp viaD-aspartate racemase; depolarization of nerve endings with potassium ions evokes an immediate release of D-Asp in a Ca2+ dependent manner; specific receptors for D-Asp occur at the postsynaptic membrane; and stimulation of nerve endings with D-Asp triggers signal transduction by increasing the second messenger cAMP." D-Asp plays an important role in the initial phases of central nervous system development in vertebrates and invertebrates. In humans, mice and chicken, large quantities of this molecule are produced in the brain during embryonic development.

After birth, D-Asp falls to minute levels and remains like this throughout adult life. Evidence suggests that the molecule is involved in the learning process and memory function in rats and enhances the cognitive capabilities of animals in a range of experiments. According to professor Jordi García-Fernàndez, "Basic research leads to advances in applied work by describing new functional mechanisms that explain the complex biological machinery of the nervous system. This study is of particular interest in the field of dementia, as it describes a novel neurotransmitter with a potential use in the treatment of certain neurological diseases (Parkinson's disease, schizophrenia, etc.)."

For the project reported in the FASEB Journal, the team from the UB's Department of Genetics analysed D-Asp content in the central nervous system of animal models, performed immunohistochemical analyses and carried out the comparative study. Although no further study of D-Asp in humans is planned in the short term, the UB team is working towards a new, related challenge: to isolate the specific receptor for D-Asp, an achievement that would represent a huge step forward in the development of possible therapeutic applications.


Story Source:

The above story is based on materials provided by Universidad de Barcelona. Note: Materials may be edited for content and length.


Journal Reference:

  1. S. D'Aniello, I. Somorjai, J. Garcia-Fernandez, E. Topo, A. D'Aniello. D-Aspartic acid is a novel endogenous neurotransmitter. The FASEB Journal, 2010; 25 (3): 1014 DOI: 10.1096/fj.10-168492

Cite This Page:

Universidad de Barcelona. "Experts discover a new neurotransmitter with potential applications in the treatment of neurological diseases." ScienceDaily. ScienceDaily, 5 May 2011. <www.sciencedaily.com/releases/2011/05/110505083735.htm>.
Universidad de Barcelona. (2011, May 5). Experts discover a new neurotransmitter with potential applications in the treatment of neurological diseases. ScienceDaily. Retrieved September 16, 2014 from www.sciencedaily.com/releases/2011/05/110505083735.htm
Universidad de Barcelona. "Experts discover a new neurotransmitter with potential applications in the treatment of neurological diseases." ScienceDaily. www.sciencedaily.com/releases/2011/05/110505083735.htm (accessed September 16, 2014).

Share This



More Health & Medicine News

Tuesday, September 16, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

EU Ministers and Experts Meet to Discuss Ebola Reponse

EU Ministers and Experts Meet to Discuss Ebola Reponse

AFP (Sep. 15, 2014) — The European Commission met on Monday to coordinate aid that the EU can offer to African countries affected by the Ebola outbreak. Duration: 00:58 Video provided by AFP
Powered by NewsLook.com
Despite The Risks, Antibiotics Still Overprescribed For Kids

Despite The Risks, Antibiotics Still Overprescribed For Kids

Newsy (Sep. 15, 2014) — A new study finds children are prescribed antibiotics twice as often as is necessary. Video provided by Newsy
Powered by NewsLook.com
FDA Eyes Skin Shocks Used at Mass. School

FDA Eyes Skin Shocks Used at Mass. School

AP (Sep. 15, 2014) — The FDA is considering whether to ban devices used by the Judge Rotenberg Educational Center in Canton, Massachusetts, the only place in the country known to use electrical skin shocks as aversive conditioning for aggressive patients. (Sept. 15) Video provided by AP
Powered by NewsLook.com
Respiratory Virus Spreads To Northeast, Now In 21 States

Respiratory Virus Spreads To Northeast, Now In 21 States

Newsy (Sep. 14, 2014) — The respiratory virus Enterovirus D68, which targets children, has spread from the Midwest to 21 states. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins